Article Text

Download PDFPDF
From BMJ Journals
Arthritis drugs are hazardous for high risk patients

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Researchers in the TARGET (Therapeutic Arthritis Research and Gastrointestinal Event Trial) study urge caution in giving cyclo-oxygenase (COX)-2 inhibitors and non-selective NSAIDs, especially ibuprofen, for osteoarthritis to patients at high cardiovascular (CVR) risk.

The trial suggests that these agents raise the risk, though a long term placebo controlled randomised trial …

View Full Text